Pacific Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -47.86%
(FY 2023)
- Profit -9.44%
(FY 2023)
- Ebitda 16.53%
(FY 2023)
- Net Worth 22.23%
(FY 2023)
- Total Assets -6.18%
(FY 2023)
About Pacific Biochem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Meena Vijaysingh and Vijay Chatar serve as directors at the Company.
- CIN/LLPIN
U24233MH2012PTC233532
- Company No.
233532
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pacific Biochem Private Limited offer?
Pacific Biochem Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Biocides, Organic and Inorganic Solvents, Alcohol Solvents, Chemical Reagents & Catalysts, Bromine Compound, Agro Chemicals, Aldehydes, Organic Chemicals, Liquid Phenol.
Who are the key members and board of directors at Pacific Biochem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meena Vijaysingh  | Director | 18-Jul-2012 | Current |
| Vijay Chatar | Director | 18-Jul-2012 | Current |
Financial Performance and Corporate Structure Insights of Pacific Biochem.
Pacific Biochem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 47.86% decrease. The company also saw a slight decrease in profitability, with a 9.44% decrease in profit. The company's net worth Soared by an impressive increase of 22.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pacific Biochem?
In 2023, Pacific Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Badlapur Common Effluent Treatment Plant AssociationActive 27 years 11 days
Vijay Chatar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pacific Biochem?
Pacific Biochem has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pacific Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pacific Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
